ITGA2B and lung cancer: In summary, similar to previously investigated prothrombotic conditions such as lupus anticoagulants and lung cancer, we found significantly increased levels of the two thrombosis-promoting protein disulfide isomerases P4HB and PDIA6 and a reduced total amount of ITGA2B in the platelets of COVID-19 patients.